1. Home
  2. LSF vs ICCM Comparison

LSF vs ICCM Comparison

Compare LSF & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSF
  • ICCM
  • Stock Information
  • Founded
  • LSF 2015
  • ICCM 2006
  • Country
  • LSF United States
  • ICCM Israel
  • Employees
  • LSF N/A
  • ICCM N/A
  • Industry
  • LSF Packaged Foods
  • ICCM
  • Sector
  • LSF Consumer Staples
  • ICCM
  • Exchange
  • LSF Nasdaq
  • ICCM Nasdaq
  • Market Cap
  • LSF 61.6M
  • ICCM 61.1M
  • IPO Year
  • LSF 2020
  • ICCM N/A
  • Fundamental
  • Price
  • LSF $5.75
  • ICCM $0.99
  • Analyst Decision
  • LSF Strong Buy
  • ICCM Strong Buy
  • Analyst Count
  • LSF 2
  • ICCM 1
  • Target Price
  • LSF $12.00
  • ICCM $2.00
  • AVG Volume (30 Days)
  • LSF 34.6K
  • ICCM 1.9M
  • Earning Date
  • LSF 11-05-2025
  • ICCM 08-13-2025
  • Dividend Yield
  • LSF N/A
  • ICCM N/A
  • EPS Growth
  • LSF N/A
  • ICCM N/A
  • EPS
  • LSF N/A
  • ICCM N/A
  • Revenue
  • LSF $47,027,546.00
  • ICCM $2,787,000.00
  • Revenue This Year
  • LSF $21.88
  • ICCM $62.11
  • Revenue Next Year
  • LSF $20.86
  • ICCM $142.91
  • P/E Ratio
  • LSF N/A
  • ICCM N/A
  • Revenue Growth
  • LSF 22.79
  • ICCM N/A
  • 52 Week Low
  • LSF $3.60
  • ICCM $0.48
  • 52 Week High
  • LSF $10.90
  • ICCM $1.66
  • Technical
  • Relative Strength Index (RSI)
  • LSF 43.26
  • ICCM 49.14
  • Support Level
  • LSF $5.68
  • ICCM $0.98
  • Resistance Level
  • LSF $5.99
  • ICCM $1.12
  • Average True Range (ATR)
  • LSF 0.25
  • ICCM 0.07
  • MACD
  • LSF 0.04
  • ICCM -0.00
  • Stochastic Oscillator
  • LSF 25.21
  • ICCM 11.82

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: